Biochemical Reagent
-
BA2318 LifastuzumabSummary: Lifastuzumab is a humanized anti-monoclonal antibody (IgG1 type). - BA2319 BriobaceptSummary: Briobacept (BR3FC) is a selectively targeted monoclonal antibody that induces apoptosis in B cells.
-
BA2320 DxdSummary: Dxd (ExatecanderivativeforADC) is a potent inhibitor. -
BA2321 MertansineSummary: Mertansine (DM1) is an inhibitor and an antibody-conjugatable medetomidine alkaloid used to overcome the systemic toxicity associated with medetomidine and to enhance tumor-specific delivery. - BA2322 ExatecanSummary: Exatecan (DX-8951) is a DNA topoisomerase I inhibitor.
- BA2323 DM4Summary: DM4 is an anti-microtubule protein agent that inhibits cell division.
- BA2324 SG3199Summary: SG3199 is a cytotoxic DNA minor groove interstrand cross-linked PBD dimer.
- BA2325 PNU-159682Summary: PNU-159682, a metabolite of anthracycline neomycin, is a DNA topoisomerase II inhibitor with excellent cytotoxicity.
- BA2326 TaltobulinSummary: Taltobulin (HTI-286) is a synthetic tripeptide cysteine analog, Taltobulin is a potent anti-microtubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
- BA2327 Seco-DUBASummary: Seco-DUBA is a doxorubicin (DUBA) prodrug containing two hydroxyl groups, each of which can be coupled to an antibody via a linker.